Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects with Moderate to Severe Hidradenitis Suppurativa Who Have
Active
$964K Funding
4 People
External
Related Topics
clinical trials,
dermatology,
immunology,
inflammatory diseases,
pharmacology
People
Luz Badilla
(CD)
Medicine
﹒Clinical Research Coordinator II
Kirsten Anderson
(CD)
Senior VP Health Sciences
﹒Research Compliance Administrator IV
Gustavo Cornejo
(CD)
Senior VP Health Sciences
﹒Research Compliance Administrator II
Daniel Butler
Principal Investigator (PI)
Medicine
﹒Associate Professor